Roche Venture Fund Appoints Anja Harmeier as New Head of Startup…

Team S · 2026-01-07T13:40:17.000Z

Roche Venture Fund, the CHF 750 million corporate venture capital arm of pharmaceutical giant Roche, has appointed Anja Harmeier as its new Head of Venture Investments, succeeding Carole Nuechterlein following her retirement. Harmeier returns to Roche’s CVC after previously serving on the investment team from 2016 to 2020 and brings additional leadership experience from her recent role as CEO of Rewind Therapeutics and as a partner at BB Pureos Bioventures, reinforcing Roche’s commitment to strategic investments in pharmaceuticals, diagnostics and digital health. #RocheVentureFund #CorporateVC #LeadershipAnnouncement #AnjaHarmeier #Roche #HealthcareVC #LifeSciences #StartupInvestment #VCLeadership #PharmaInnovation #DigitalHealth #BiotechInvesting #CVC

Member Login Get Access

Roche Venture Fund Appoints Anja Harmeier as New Head of Startup… | Newnex